Truly transformative healthcare companies often solve "boring" but fundamental problems. Instead of tackling surface-level symptoms (e.g., appointment booking), the best founders dig deep to fix the complex, underlying infrastructure issues of the healthcare system, creating a durable competitive moat.

Product stickiness in health systems is achieved through deep workflow integration. By embedding a solution into the daily processes of every stakeholder—from medical assistants to billing coordinators—it becomes entrenched and difficult to replace, mirroring the zero-churn model of EMR giant Epic.

Two dominant strategies are winning. Companies can either be the absolute best at one specific thing (e.g., musculoskeletal care, women's health) or build a platform that aggregates these best-in-class solutions into a seamless 'digital front door' for insurers and corporations.

ZocDoc's defensibility isn't just technology; it's the ever-deepening operational complexity of the U.S. healthcare system. CEO Oliver Karaz likens this to mapping England's coastline—the closer you look, the more intricate it gets, creating a massive, hard-to-replicate moat built on deep domain knowledge.

While large language models (LLMs) are powerful general tools, they will be outcompeted in specific verticals by specialized AI applications. These niche products, like Calm for meditation, win by providing superior design, features, and community tailored to a dedicated user base.

Doximity integrates multiple workflow tools like telehealth and e-signatures. While specialized competitors might offer better individual products, Doximity wins by providing a convenient, all-in-one platform that doctors are already engaged with daily, creating a powerful defensive moat.

A large customer support organization signals that a product is too complex, hard to onboard, or buggy. Instead of optimizing the support function, companies should focus on improving the product to the point where extensive human support becomes unnecessary.

Instead of competing on diagnostics, Anthropic is positioning its Claude model as an 'orchestrator' to unify disparate health data for patients and providers. This strategy targets a major pain point—system navigation and data integration—rather than directly challenging established medical AI use cases, carving out a unique enterprise niche.

The primary challenge for direct-to-consumer (DTC) AI doctor services is not technology but economics. High customer acquisition costs and churn make a standalone subscription model untenable. Successful AI doctors will likely be a top-of-funnel feature for a larger, integrated healthcare business.